Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: a systematic review and meta-analysis

BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality with incidence rates of 5–10 per 1000 person-years, according to primary prevention studies. To control hyperlipidemia—a major risk factor of cardiovascular disease—initiation of lipid-lowering therapy with therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hsin-Yin, Lin, Chien-Ju, Lee, Yu-Shan, Wu, Ting-Hui, Chien, Kuo-Liong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359015/
https://www.ncbi.nlm.nih.gov/pubmed/32660417
http://dx.doi.org/10.1186/s12872-020-01567-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359015/
https://www.ncbi.nlm.nih.gov/pubmed/32660417
http://dx.doi.org/10.1186/s12872-020-01567-1

Ejemplares similares